The clearance positions Insulet to sell the integrated Type 1 diabetes product in Europe beginning in the first half of the year.

BOCA RATON, Fla., Feb. 08, 2024 (GLOBE NEWSWIRE) — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that the U.S. Patent and Trademark Office (USPTO) has issued Patent No. 11,894,123 B2, titled “Radiotherapy Mobile and Wireless Device Workflow Management System.”

Fresenius Medical Care announced today that it received FDA clearance for its 5008X hemodialysis system.